GSK plc ADR buy Guggenheim
Start price
04.03.24
/
50%
€38.80
Target price
04.03.25
-
Performance (%)
-7.22%
End price
05.03.25
€36.00
Summary
This prediction ended on 05.03.25 with a price of €36.00. With a performance of -7.22%, the BUY prediction for GSK plc ADR by Guggenheim closed slightly in the red. Dividends of €1.45 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -1.923% | -1.923% | 25.926% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Guggenheim for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten